Shoulder Innovations (SI) – Investment Analysts’ Weekly Ratings Updates

A number of research firms have changed their ratings and price targets for Shoulder Innovations (NYSE: SI):

• 12/15/2025 – Shoulder Innovations had its “sell (e)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – Shoulder Innovations had its “sell (e)” rating reaffirmed by analysts at Weiss Ratings.
• 12/2/2025 – Shoulder Innovations had its price target raised by analysts at Morgan Stanley from $18.00 to $23.00. They now have an “overweight” rating on the stock.
• 12/1/2025 – Shoulder Innovations had its “sell (e)” rating reaffirmed by analysts at Weiss Ratings.
• 11/25/2025 – Shoulder Innovations had its “sell (e)” rating reaffirmed by analysts at Weiss Ratings.
• 11/19/2025 – Shoulder Innovations had its “sell (e)” rating reaffirmed by analysts at Weiss Ratings.
• 11/12/2025 – Shoulder Innovations had its “overweight” rating reaffirmed by analysts at Piper Sandler. They now have a $18.00 price target on the stock.
• 10/24/2025 – Shoulder Innovations is now covered by analysts at Weiss Ratings. They set a “sell (e)” rating on the stock.

Insider Activity at Shoulder Innovations

In related news, CEO Robert Joseph Ball purchased 3,900 shares of the stock in a transaction dated Friday, December 12th. The shares were acquired at an average cost of $14.89 per share, with a total value of $58,071.00. Following the purchase, the chief executive officer directly owned 118,457 shares in the company, valued at $1,763,824.73. This trade represents a 3.40% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. In the last 90 days, insiders have acquired 9,200 shares of company stock worth $136,642. 1.71% of the stock is currently owned by insiders.

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.